Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02049957
Title Safety and Efficacy Study of MLN0128 in Combination With Exemestane or Fulvestrant in Postmenopausal Women With ER/PR+ Metastatic Breast Cancer
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications

estrogen-receptor positive breast cancer

Her2-receptor negative breast cancer

Therapies

Fulvestrant + Sapanisertib

Exemestane + Sapanisertib

Age Groups: adult
Covered Countries USA | FRA | BEL

Facility Status City State Zip Country Details
Los Angeles Hematology Los Angeles California 90017 United States Details
University of California at San Francisco (PARENT) San Francisco California 94143 United States Details
Santa Barbara Hematology Oncology Medical Group, Inc. Santa Barbara California 93105 United States Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Rocky Mountain Cancer Centers, LLP Lakewood Colorado 80228 United States Details
Mount Sinai Medical Center Miami Beach Florida 33140 United States Details
Florida Cancer Research Institute Plantation Florida 33324 United States Details
University of Kansas Medical Center Research Institute, Inc. Westwood Kansas 66205 United States Details
Holy Cross Hospital Silver Spring Maryland 20910 United States Details
Henry Ford Medical Center Novi Michigan 48322 United States Details
University of Minnesota Minneapolis Minnesota 55455 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Eastchester Center for Cancer Care / BRANY Bronx New York 10469 United States Details
Roswell Park Cancer Institute Buffalo New York 14263-0001 United States Details
Herbert Irving Comprehensive Cancer Center New York New York 10032 United States Details
Weill Cornell Medical College New York Presbyterian Hospital New York New York 10065 United States Details
University of Cincinnati Physicians Company, LLC Cincinnati Ohio 45267-0502 United States Details
University Hospitals of Cleveland Cleveland Ohio 44106 United States Details
Erlanger Medical Center Chattanooga Tennessee 37403 United States Details
Texas Oncology, P.A. - Beaumont Beaumont Texas 77702-1449 United States Details
Texas Oncology, P.A. Dallas Texas 75246 United States Details
UT Southwestern Medical Center Dallas Texas 75390-9085 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Millennium Oncology Houston Texas 77090 United States Details
Texas Health Physicians Group Plano Texas 75093 United States Details
Cancer Care Network of South Texas - SAT&BC San Antonio Texas 78217 United States Details
Texas Oncology, P.A. - Tyler Tyler Texas 75702 United States Details
Virginia Oncology Associates - Hampton Chesapeake Virginia 23320 United States Details
Oncology and Hematology Assoc. of SW VA, Inc. Salem Virginia 24153 United States Details
West Virginia University Morgantown West Virginia 26506 United States Details
UZ Antwerpen Antwerpen 2650 Belgium Details
Institut Jules Bordet Bruxelles 1000 Belgium Details
Universitair Ziekenhuis Brussel Bruxelles 1090 Belgium Details
GHdC Notre Dame Charleroi 6000 Belgium Details
Centre Hospitalier de l'Ardenne Libramont 6800 Belgium Details
GZA Ziekenhuizen - Campus Sint-Augustinus Wilrijk 2610 Belgium Details
Centre Francois Baclesse Caen Cedex 05 Calvados 14076 France Details
Centre Catherine de Sienne Nantes Loire Atlantique 44202 France Details
Clinique Victor Hugo - Centre Jean Bernard Le Mans Cedex 02 Sarthe 72015 France Details
Institut Sainte Catherine Avignon Vaculuse 84000 France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field